I-Therapeutix Sees $6 Million Series B Round

Wade Roush3/7/08

I-Therapeutix is a Waltham, MA-based startup commercializing a hydrogel, or water-based polymer, as a temporary sealant for eye wounds left by cataract surgery. CEO Amir Sawhney told Mass High Tech in January that the company expected to close a $6 million Series B funding round soon, led by Versant Ventures of California and SV Life Sciences of Boston, with participation by Pinnacle Ventures of Palo Calto, CA, and angel investors. And today we’re hearing second-hand (via Private Equity Hub, which attributes the story to VentureWire) that the round has indeed closed, bringing the company’s total financing to $7.2 million.

Wade Roush is Xconomy's chief correspondent and editor of Xconomy San Francisco. You can e-mail him at wroush@xconomy.com or follow him on Twitter at twitter.com/wroush.